has been cited by the following article(s):
|
[1]
|
Effect of Gabapentin-Fluoxetine Derivative GBP1F in a murine model of depression, anxiety and cognition
|
|
Drug Design …,
2023 |
|
|
|
|
[2]
|
Rosuvastatin ameliorates anxiety but impairs skeletal muscle performance by malondialdehyde and calcium depletion in high fat diet-fed swiss albino mice
|
|
Journal of African Association of …,
2023 |
|
|
|
|
[3]
|
Modulatory effect of gut microbiota on the gut-brain, gut-bone axes, and the impact of cannabinoids
|
|
Metabolites,
2022 |
|
|
|
|
[4]
|
Modulatory Effect of Gut Microbiota on the Gut-Brain, Gut-Bone Axes, and the Impact of Cannabinoids. Metabolites 2022, 12, 1247
|
|
2022 |
|
|
|
|
[1]
|
Omega-3 fatty acids: multi-target mechanisms and therapeutic applications in neurodevelopmental disorders and epilepsy
Frontiers in Nutrition,
2025
DOI:10.3389/fnut.2025.1598588
|
|
|
|
|
[2]
|
Cannabis and Derivatives
2024
DOI:10.1016/B978-0-443-15489-8.00005-0
|
|
|
|
|
[3]
|
Effect of Gabapentin-Fluoxetine Derivative GBP1F in a Murine Model of Depression, Anxiety and Cognition
Drug Design, Development and Therapy,
2023
DOI:10.2147/DDDT.S407229
|
|
|
|
|
[4]
|
Modulatory Effect of Gut Microbiota on the Gut-Brain, Gut-Bone Axes, and the Impact of Cannabinoids
Metabolites,
2022
DOI:10.3390/metabo12121247
|
|
|
|